General
Doxycycline Post-Exposure Prophylaxis (doxy-PEP) for the Prevention of Sexually Transmitted Infections
Increased Numbers of West Nile Cases in New Mexico in 2023 - August 18, 2023
As the number of COVID-19 cases rises across the US, the New Mexico Department of Health recommends that providers prescribe Paxlovid (nirmatrelvir/ritonavir) to all appropriate patients diagnosed with COVID-19. Paxlovid, an oral antiviral, is a highly effective treatment for COVID-19 but continues to be under prescribed by providers1. Support for the use of Paxlovid comes from several randomized trials and observational studies of symptomatic outpatients with COVID-19, which demonstrated a reduction in hospitalization and death.